Home > Insider Trading > Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc. (AMPH)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
21 - 30
Next >>

Amphastar Pharmaceuticals Inc (AMPH): Hedge Funds In Wait-and-See Mode

We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March...

Keep Reading →

June 12th, 2020 - Hedge Funds News

Here is What Hedge Funds Think About Amphastar Pharmaceuticals Inc (AMPH)

A whopping number of 13F filings filed with U.S.

Keep Reading →

December 17th, 2019 - Hedge Funds News

Is Amphastar Pharmaceuticals Inc (AMPH) A Good Stock To Buy?

Is Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock.

Keep Reading →

October 28th, 2019 - Hedge Funds News

Is Amphastar Pharmaceuticals Inc (AMPH) A Good Stock To Buy ?

Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips.

Keep Reading →

June 29th, 2019 - Hedge Funds News

Here's What Hedge Funds Think About Amphastar Pharmaceuticals Inc (AMPH)

Hedge funds and other investment firms run by legendary investors like Israel Englander, Jeffrey Talpins and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money because...

Keep Reading →

May 7th, 2019 - Hedge Funds News

Is Amphastar Pharmaceuticals Inc (AMPH) A Good Stock To Buy?

The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small...

Keep Reading →

December 23rd, 2018 - Hedge Funds News

Hedge Fund and Insider Trading News: Ken Griffin, Elliott Management Corp., AutoNation, Inc. (AN), Loxo Oncology Inc (LOXO), Amphastar Pharmaceuticals Inc (AMPH), and More

Citadel, the more than $30 billion hedge fund managed by billionaire Ken Griffin, is outperforming the industry and the broader markets so far this year.

Keep Reading →

July 13th, 2018 - Hedge Funds Insider Trading

Hedge Fund and Insider Trading News: Alan Fournier, Coatue Management, D. E. Shaw & Co. L.P., Amphastar Pharmaceuticals Inc (AMPH), USANA Health Sciences, Inc. (USNA), and More

Hedge fund manager Alan Fournier is returning client capital at his $1.5 billion Pennant Capital Management after almost two decades, the latest veteran stock-picker to close his fund following struggles...

Keep Reading →

March 28th, 2018 - Hedge Funds Insider Trading

Do Hedge Funds Love Amphastar Pharmaceuticals Inc (AMPH)?

There are several ways to beat the market, and investing in small cap stocks has historically been one of them.

Keep Reading →

December 12th, 2016 - Hedge Funds News

Is Amphastar Pharmaceuticals Inc (AMPH) A Good Stock To Buy?

The third quarter was a rough one for most investors, as fears of an interest rate hike in the U.S, a weakening economy in China, and a stagnant Europe, weighed heavily on the minds of investors.

Keep Reading →

December 6th, 2015 - Hedge Funds News